---  
layout: startup_page  
title: "Neuron23"  
id: "neuron23.com"  
permalink: "/neuron23neuron23.com06242025/"  
website: "https://www.neuron23.com"  
funding_round: "Series D"  
funding_amount: "$96.5M"  
investors: "Westlake Village BioPartners, SoftBank Vision Fund 2, Redmile Group, Blue Owl, Kleiner Perkins, HBM Healthcare Investments (Cayman) Ltd., Acorn Bioventures, a healthcare investor"  
about: "Neuron23 is a clinical-stage biotechnology company specializing in precision medicines for genetically defined neurological and immunological diseases. They are focused on developing therapeutics using advanced techniques in machine learning and artificial intelligence for neurodegenerative diseases, neuroinflammatory diseases, and systemic autoimmune and inflammatory diseases. Their current focus is on NEU-411, a LRRK2 inhibitor for early Parkinson's disease."  
markets: "Biotech, Healthtech, Pharmaceutical"  
hq: "South San Francisco, California, United States"  
founded_year: "2018"  
linkedin: "https://www.linkedin.com/company/neuron23-inc/"  
twitter: "https://x.com/official_N23"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/neuron23"  
pitchbook: "https://pitchbook.com/profiles/company/265320-91"  

date_display: "24-Jun-2025"  
date: "2025-06-24"

# SEO Optimization  
meta_title: "Neuron23 - Series D Funding ($96.5M)"  
meta_description: "Neuron23, Neuron23 is a clinical-stage biotechnology company specializing in precision medicines for genetically defined neurological and immunological diseases..."  
meta_keywords: "Neuron23, Biotech, Healthtech, Pharmaceutical, Series D funding"  
canonical_url: "https://startup.projectstartups.com/neuron23neuron23.com06242025/"  
---